Category - Developments

Developments

Arch advances 510(k) filing for AC5 hemostat

Arch Therapeutics (OTCQB:ARTH) announced that the 510(k) filing for external use of the AC5 Topical Hemostatic device would be advanced to mid-2017 from the previously announced target of late 2017. “Our...

February 17, 2017

Developments

Montreal Heart Institute implements Stereotaxis systems

Stereotaxis (NASDAQ:STXS) announced that the Montreal Heart Institute (MHI) is now performing ablation procedures using its newly installed Niobe ES and the Vdrive robotic systems. MHI is the first hospital in...

February 16, 2017

Developments

Benefits of Titan’s Probuphine featured in DDBN

Drug Deliver Business News has carried an article about Titan Pharmaceuticals (NASDAQ:TTNP) and its Probuphine implant, the first marketed product to provide maintenance treatment for opioid addiction continuously for...

February 14, 2017

Developments

Microbix posts 84% jump in Q1 revenue

Microbix Biosystems (TSX:MBX) reported that revenue rose 84% to almost $2-million for the first quarter ended Dec. 31, 2016, from $1.1-million a year earlier. Strong growth in Asian markets and increased sales to the...

February 14, 2017

Developments

YouScript study shows reduced ER visits and readmissions

YouScript, a clinical decision support tool designed to assist in medication therapy management, has been shown to reduce hospital readmissions by 52% and ER visits by 42% in patients over 50 taking multiple medications...

February 7, 2017

Developments

BioTime acquires rights to retinal disease assets

BioTime (NYSE MKT:BTX) has acquired global rights to ophthalmology-related intellectual property assets from the University of Pittsburgh’s Medical Center, via the school’s Innovation Institute. The technology was...

February 6, 2017

Developments

Avivagen undertakes human health proof of concept

Avivagen (TSX-V:VIV), with the help of the National Research Council of Canada (NRC), will undertake a project to establish proof of concept for a first human health application of its OxC-beta technology. The project...

February 3, 2017

Developments

Mass. Life Sciences launches ramp-up program

The Massachusetts Life Sciences Center (MLSC) has launched the Massachusetts Ramp-Up Program (MassRamp), a new program that will provide grant funding to promising early-stage life sciences companies. The program will...

January 31, 2017

Developments

Researchers train computer to identify skin cancer

A team of Stanford researchers trained a computer to identify images of skin cancer moles and lesions as accurately as a dermatologist, according to a new paper published in the journal, Nature. The new research...

January 26, 2017

Developments

FDA accepts Adamis NDA resubmission

The FDA has accepted for review Adamis Pharmaceuticals’ (NASDAQ:ADMP) NDA for its Epinephrine Pre-filled Syringe (PFS) product candidate for the emergency treatment of anaphylaxis. Filed last Dec. 15, the resubmission...

January 19, 2017

Category - Developments

Subscribe